Home > Executive Order

AI Summary: This is a policy document, specifically an Executive Order (EO 14256) addressing duties on low-value imports from China and Hong Kong related to the synthetic opioid supply chain. This regulation eliminates duty-free de minimis treatment for low-value products (valued at or under $800) imported from the People's Republic of China (PRC) and Hong Kong through the international postal network, effective May 2, 2025. The order requires all such shipments to pay additional duties, with carriers having two options for duty payment: either a 30% ad valorem duty or a flat per-package fee (starting at $25 and increasing to $50 on June 1, 2025). Carriers must report package details to U.S. Customs and Border Protection (CBP), obtain an international carrier bond, and use the Automated Commercial Environment (ACE) for entry. The order aims to address concerns about illicit substances being shipped from China by removing the previous duty-free exemption. The Secretary of Commerce is required to submit a report within 90 days assessing the order's impact on American industries, consumers, and supply chains, and potentially recommending further actions such as extending the de minimis ineligibility to packages from Macau.